Professor Kim Donaghue holds the position of Associate Professor in the Westmead Clinical School at the University of Sydney, within the Faculty of Medicine and Health. She is a paediatric endocrinologist at the Institute of Endocrinology and Diabetes, The Children's Hospital at Westmead, where she heads the Diabetes Complications Assessment Service. Donaghue completed her Bachelor of Medicine and Bachelor of Surgery in 1979 and her PhD in Medicine in 2001, both at the University of Sydney. She is a Fellow of the Royal Australasian College of Physicians (FRACP). Her academic career at the University of Sydney spans clinical practice, teaching, and extensive research focused on diabetes in children and adolescents.

Listed as Professor on Google Scholar with research interests explicitly in diabetes, Donaghue has amassed over 21,000 citations. Her key publications include leading authorship on the ISPAD Clinical Practice Consensus Guidelines 2018: Microvascular and Macrovascular Complications in Children and Adolescents (399 citations), co-authorship on Clinical Targets for Continuous Glucose Monitoring Data Interpretation (2019, 4544 citations), Global Incidence, Prevalence, and Mortality of Type 1 Diabetes in 2021 with Projection to 2040 (2022, 1267 citations), Definition, Epidemiology and Classification of Diabetes in Children and Adolescents (2009, 726 citations), Prevalence of Diabetes Complications in Adolescents with Type 2 Compared with Type 1 Diabetes (2006, 631 citations), and Microvascular and Macrovascular Complications Associated with Diabetes in Children and Adolescents (2009, 288 citations). She has contributed to major multi-center studies such as the Adolescent Cardio-Renal Intervention Trial (AdDIT) examining cardio-renal protective interventions in youth with type 1 diabetes. Donaghue served as President of the International Society for Pediatric and Adolescent Diabetes (ISPAD) and received the ISPAD Prize for Achievement in 2022 as well as the ANZSPED Medal in 2015. Her guidelines and research have profoundly influenced screening protocols, management strategies, and international consensus on preventing diabetes complications in pediatric populations, enhancing clinical outcomes worldwide.

Professional Email: kim.donaghue@sydney.edu.au